{
  "company": {
    "name": "Areteia Therapeutics",
    "website": "https://areteiatx.com/",
    "record": "https://startuphistory.org/c/areteiatx.com"
  },
  "status": null,
  "history_since": "2022-07-12T11:50:15.000Z",
  "baseline": {
    "snapshot_id": "3d06afc724a49c41fe8e07c2b25365e65c411f2c24aaa355ef1b58b70f69a167",
    "observed_at": "2022-07-12T11:50:15.000Z",
    "headline": "Pioneering a new era in asthma control",
    "description": null,
    "evidence": "https://web.archive.org/web/20220712115015/https://www.areteiatx.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-05T11:25:00.102Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2025-08-06T14:45:05.000Z",
      "variants": [
        {
          "headline": "Pioneering a new era in asthma control",
          "subhead": null,
          "observed_at": "2022-07-12T11:50:15.000Z",
          "evidence": "https://web.archive.org/web/20220712115015/https://www.areteiatx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Pioneering a new era in asthma control",
          "subhead": "Areteia Therapeutics is a new biotechnology company committed to putting asthma patients in better control of their disease—and back in control of their lives—with the first potential oral drug for eo",
          "observed_at": "2023-01-17T18:08:10.000Z",
          "evidence": "https://web.archive.org/web/20230117180810/https://www.areteiatx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Pioneering a new era in asthma control",
          "subhead": "Areteia Therapeutics is a new biotechnology company committed to putting asthma patients in better control of their disease—and back in control of their lives—with the first potential oral drug for eo",
          "observed_at": "2023-09-26T09:02:20.000Z",
          "evidence": "https://web.archive.org/web/20230926090220/https://areteiatx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Pioneering a new era in inflammatory airway disease",
          "subhead": "Areteia Therapeutics is a new biotechnology company committed to putting asthma patients in better control of their disease—and back in control of their lives—with the first potential oral drug for eo",
          "observed_at": "2024-01-04T11:58:17.000Z",
          "evidence": "https://web.archive.org/web/20240104115817/https://areteiatx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Pioneering a new era in inflammatory airway disease",
          "subhead": "Areteia Therapeutics is a new biotechnology company committed to putting asthma patients in better control of their disease—and back in control of their lives—with the first potential oral drug for eo",
          "observed_at": "2024-07-15T14:48:17.000Z",
          "evidence": "https://web.archive.org/web/20240715144817/https://www.areteiatx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Pioneering a new era in inflammatory airway disease",
          "subhead": "Areteia Therapeutics is a new biotechnology company committed to putting asthma patients in better control of their disease—and back in control of their lives—with the first potential oral drug for eo",
          "observed_at": "2025-01-01T06:14:13.000Z",
          "evidence": "https://web.archive.org/web/20250101061413/https://areteiatx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Pioneering a new era in inflammatory airway disease",
          "subhead": "Areteia Therapeutics is a new biotechnology company committed to putting asthma patients in better control of their disease—and back in control of their lives—with the first potential oral drug for eo",
          "observed_at": "2025-08-06T14:45:05.000Z",
          "evidence": "https://web.archive.org/web/20250806144505/https://areteiatx.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Pioneering a new era in inflammatory airway disease",
      "subhead": "Areteia Therapeutics is a new biotechnology company committed to putting asthma patients in better control of their disease—and back in control of their lives—with the first potential oral drug for eo",
      "from": "2022-07-12T11:50:15.000Z",
      "to": "2025-08-06T14:45:05.000Z",
      "captures": 7,
      "evidence": "https://web.archive.org/web/20250806144505/https://areteiatx.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2022-07-12T11:50:15.000Z",
          "to": "2025-08-06T14:45:05.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-05T11:25:00.102Z",
      "variants": [
        {
          "headline": "Areteia Therapeutics, Inc.",
          "subhead": null,
          "observed_at": "2026-01-18T11:03:57.000Z",
          "evidence": "https://web.archive.org/web/20260118110357/https://www.areteiatx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Areteia Therapeutics, Inc.",
          "subhead": null,
          "observed_at": "2026-07-07T18:26:25.000Z",
          "evidence": "https://web.archive.org/web/20260707182625/https://areteiatx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Areteia Therapeutics, Inc.",
          "subhead": null,
          "observed_at": "2026-10-27T20:23:10.000Z",
          "evidence": "https://web.archive.org/web/20261027202310/https://www.areteiatx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Areteia Therapeutics, Inc.",
          "subhead": null,
          "observed_at": "2026-11-05T11:25:00.102Z",
          "evidence": "https://areteiatx.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Areteia Therapeutics, Inc.",
      "subhead": null,
      "from": "2026-01-18T11:03:57.000Z",
      "to": "2026-11-05T11:25:00.102Z",
      "captures": 4,
      "evidence": "https://areteiatx.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2026-01-18T11:03:57.000Z",
          "to": "2026-11-05T11:25:00.102Z"
        }
      },
      "current": true
    }
  ],
  "changes": [],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Areteia Therapeutics” company record, https://startuphistory.org/c/areteiatx.com"
}